Cargando…

COVID-19 and Mucormycosis Coinfection: How Challenging It Is

Recently, cases of rhinoorbital mucormycosis in people diagnosed with COVID-19 have been reported from India particularly. Diabetes mellitus though happens to be an independent risk factor both for severe COVID-19 and mucormycosis, administration of steroids is attributed as a precipitating factor f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nayak, Niranjan, Khan, Erum, Panigrahi, Debadatta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010177/ https://www.ncbi.nlm.nih.gov/pubmed/35432662 http://dx.doi.org/10.1155/2022/8617212

Ejemplares similares

COVID-19 Coinfection With Mucormycosis in a Diabetic Patient
por: R, Roopa, et al.
Publicado: (2021)

Disseminated tuberculosis and gastric mucormycosis coinfection
por: Malek, Alexandre, et al.
Publicado: (2019)

Mucormycosis coinfection post-COVID-19 recovery: Early suspicion and prompt action
por: Kulkarni, Vishal, et al.
Publicado: (2022)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult
por: Sun, George, et al.
Publicado: (2023)

Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum
por: Devnath, Popy, et al.
Publicado: (2021)

Rise of mucormycosis during the COVID-19 pandemic and the challenges faced
por: Kottarathil, Malavika, et al.
Publicado: (2023)

Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
por: Hu, Zhi-min, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

The microbiota-related coinfections in COVID-19 patients: a real challenge
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
por: Azhar, Asim, et al.
Publicado: (2022)

Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic
por: Sharma, Ayushi, et al.
Publicado: (2022)

Initial and ongoing challenges with COVID-19-associated mucormycosis
por: Sikka, Kapil, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
por: García-Carnero, Laura C., et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
por: Yasmin, Farah, et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022)

The microbial coinfection in COVID-19
por: Chen, Xi, et al.
Publicado: (2020)

Role of Dentist: COVID19 and Mucormycosis
por: Almutairi, Faris Jaser, et al.
Publicado: (2022)

Coinfections in Intensive Care Unit with pulmonary tuberculosis and mucormycosis: A clinical dilemma
por: Dube, Pratibha, et al.
Publicado: (2016)

Leishmaniasis–HIV coinfection: current challenges
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2016)

Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review
por: Sengupta, Indraneel, et al.
Publicado: (2022)

COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges
por: Abd El-Baky, Rehab Mahmoud, et al.
Publicado: (2023)

COVID-19 and mucormycosis superinfection: the perfect storm
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2021)

COVID-19 associated mucormycosis (CAM) in India: a formidable challenge
por: Rao, Vishal U.S., et al.
Publicado: (2021)

Fostering a deeper understanding of COVID-19-associated mucormycosis – A commentary on “The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum” (Int. J. Surg. 2021:106031)
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2021)

COVID-19 associated mucormycosis – An emerging threat
por: Chao, Chien-Ming, et al.
Publicado: (2022)

COVID19 associated mucormycosis: A review
por: Palanisamy, Priyadharsini R., et al.
Publicado: (2022)

Oral Mucormycosis: An Inevitable Complication of COVID-19
por: Kulkarni, Madhura Dattatraya, et al.
Publicado: (2022)

Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients
por: Monika, P., et al.
Publicado: (2022)

Radiological spectrum of invasive mucormycosis in COVID-19
por: Passi, Nandini, et al.
Publicado: (2022)

Resolving the equation between mucormycosis and COVID-19 disease
por: Pasrija, Ritu, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis
por: Tazeem, Sana, et al.
Publicado: (2023)

Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review
por: Shah, Naveed Nazir, et al.
Publicado: (2022)

Mucormycosis co-infection in COVID-19 patients: An update
por: Alkhamiss, Abdullah S., et al.
Publicado: (2022)

Cavitary pulmonary tuberculosis with COVID-19 coinfection
por: Yousaf, Zohaib, et al.
Publicado: (2020)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

Mucormycosis in COVID-19 patients
por: Sundaram, Natarajan, et al.
Publicado: (2021)

ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
por: Loyola-Cruz, Miguel Ángel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4mf3m7l1o7e7uubtg2s0ofuaio